miRNA in Parkinson's disease: From pathogenesis to theranostic approaches
Abstract Parkinson's disease (PD) is an age associated neurological disorder which is specified by cardinal motor symptoms such as tremor, stiffness, bradykinesia, postural instability, and non‐motor symptoms. Dopaminergic neurons degradation in substantia nigra region and aggregation of αSyn are the classic signs of molecular defects noticed in PD pathogenesis. The discovery of microRNAs (miRNA) predicted to have a pivotal part in various processes regarding regularizing the cellular functions. Studies on dysregulation of miRNA in PD pathogenesis has recently gained the concern where our review unravels the role of miRNA expression in PD and its necessity in clinical validation for therapeutic development in PD. Here, we discussed how miRNA associated with ageing process in PD through molecular mechanistic approach of miRNAs on sirtuins, tumor necrosis factor‐alpha and interleukin‐6, dopamine loss, oxidative stress and autophagic dysregulation. Further we have also conferred the expression of miRNAs affected by SNCA gene expression, neuronal differentiation and its therapeutic potential with PD. In conclusion, we suggest more rigorous studies should be conducted on understanding the mechanisms and functions of miRNA in PD which will eventually lead to discovery of novel and promising therapeutics for PD..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:238 |
|---|---|
| Enthalten in: |
Journal of Cellular Physiology - 238(2023), 2, Seite 329-354 |
| Beteiligte Personen: |
Elangovan, Ajay [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 Wiley Periodicals LLC. |
|---|
| Umfang: |
26 |
|---|
| doi: |
10.1002/jcp.30932 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY016072731 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY016072731 | ||
| 003 | DE-627 | ||
| 005 | 20231111172209.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/jcp.30932 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_JCP_2023_238_2.zip.xml |
| 035 | |a (DE-627)WLY016072731 | ||
| 035 | |a (WILEY)JCP30932 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Elangovan, Ajay |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a miRNA in Parkinson's disease: From pathogenesis to theranostic approaches |
| 264 | 1 | |c 2023 | |
| 300 | |a 26 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 Wiley Periodicals LLC. | ||
| 520 | |a Abstract Parkinson's disease (PD) is an age associated neurological disorder which is specified by cardinal motor symptoms such as tremor, stiffness, bradykinesia, postural instability, and non‐motor symptoms. Dopaminergic neurons degradation in substantia nigra region and aggregation of αSyn are the classic signs of molecular defects noticed in PD pathogenesis. The discovery of microRNAs (miRNA) predicted to have a pivotal part in various processes regarding regularizing the cellular functions. Studies on dysregulation of miRNA in PD pathogenesis has recently gained the concern where our review unravels the role of miRNA expression in PD and its necessity in clinical validation for therapeutic development in PD. Here, we discussed how miRNA associated with ageing process in PD through molecular mechanistic approach of miRNAs on sirtuins, tumor necrosis factor‐alpha and interleukin‐6, dopamine loss, oxidative stress and autophagic dysregulation. Further we have also conferred the expression of miRNAs affected by SNCA gene expression, neuronal differentiation and its therapeutic potential with PD. In conclusion, we suggest more rigorous studies should be conducted on understanding the mechanisms and functions of miRNA in PD which will eventually lead to discovery of novel and promising therapeutics for PD. | ||
| 700 | 1 | |a Venkatesan, Dhivya |4 aut | |
| 700 | 1 | |a Selvaraj, Priyanka |4 aut | |
| 700 | 1 | |a Pasha, Md. Younus |4 aut | |
| 700 | 1 | |a Babu, Harysh Winster Suresh |4 aut | |
| 700 | 1 | |a Iyer, Mahalaxmi |4 aut | |
| 700 | 1 | |a Narayanasamy, Arul |4 aut | |
| 700 | 1 | |a Subramaniam, Mohana Devi |4 aut | |
| 700 | 1 | |a Valsala Gopalakrishnan, Abilash |4 aut | |
| 700 | 1 | |a Kumar, Nachimuthu Senthil |4 aut | |
| 700 | 1 | |a Vellingiri, Balachandar |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Cellular Physiology |g 238(2023), 2, Seite 329-354 |w (DE-627)WLY008072035 |x 10974652 |7 nnns |
| 773 | 1 | 8 | |g volume:238 |g year:2023 |g number:2 |g pages:329-354 |g extent:26 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 238 |j 2023 |e 2 |h 329-354 |g 26 | ||